Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine Oxidases, Biochemistry, vol.48, pp.4220-4230, 2009. ,
Monoamine Oxidases: The Biochemistry of the Proteins As Targets in Medicinal Chemistry and Drug Discovery, Curr. Top. Med. Chem, vol.12, pp.2189-2209, 2012. ,
A Review in Parkinson's Disease, CNS Drugs, vol.31, pp.169-176, 2017. ,
,
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias, Brain, vol.127, pp.2747-2754, 2004. ,
Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing, Oxid. Med. Cell. Longev, p.3017947, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02446034
,
,
, Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes, p.27
, Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions. Cancer Cell, vol.31, pp.368-382, 2017.
Macrophages dispose of catecholamines in adipose tissue ,
Chromone: A Valid Scaffold in Medicinal Chemistry, Chem. Rev, vol.114, pp.4960-4992, 2014. ,
Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances, J. Med. Chem, vol.60, pp.7941-7957, 2017. ,
,
, Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors
, Med. Chem. Lett, vol.21, pp.707-709, 2011.
,
, Monoamine Oxidase Inhibitors. J. Med. Chem, vol.54, pp.5165-5173, 2011.
Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry, Chem. Comm, vol.51, pp.2832-2835, 2015. ,
Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors, J. Med. Chem, vol.59, pp.5879-5893, 2016. ,
,
, Oxidase Inhibitors: Ten Years of Docking Studies, Curr. Top. Med. Chem, vol.12, pp.2145-2162, 2012.
,
Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs, J. Med. Chem, vol.50, pp.5848-5852, 2007. ,
Preferred Hydrogen-Bonding Partners of Cysteine: Implications for Regulating Cys Functions, J. Phys. Chem. B, vol.120, pp.10288-10296, 2016. ,
,
Automating crystallographic structure solution and refinement of protein-ligand complexes, Acta Crystallogr. D, vol.70, pp.144-154, 2014. ,
Functional Role of the "Aromatic Cage" in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins, Biochemistry, vol.45, pp.4775-4784, 2006. ,
Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan, Class. J. Med. Chem, vol.47, pp.1767-1774, 2004. ,
A One-Step Fluorometric Method for the ,
, Continuous Measurement of Monoamine Oxidase Activity. Anal. Biochem, vol.253, pp.169-174, 1997.
Tight Binding Inhibitors, Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, pp.304-317, 2000. ,
Tight-binding inhibitors-II: Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and 29 of human erythrocytic adenosine deaminase by coformycin, Biochem. Pharmacol, vol.24, pp.2187-2197, 1975. ,
High-Level Expression of Human Liver Monoamine Oxidase A in Pichia pastoris: Comparison with the Enzyme Expressed in Saccharomyces cerevisiae, Protein Expr. Purif, vol.24, pp.152-162, 2002. ,
,
, Human Liver Monoamine Oxidase B in Pichia pastoris, Protein Expr. Purif, vol.20, pp.334-345, 2000.
A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors, Acta Crystallogr. D, vol.127, pp.125-132, 1972. ,
, Collaborative Computational Project, N. The CCP4 Suite: Programs for protein Crystallography, Acta Crystallogr, vol.50, pp.760-767, 1994.
Features and development of Coot, Acta Crystallogr. D, pp.486-501, 2010. ,
Vagin, A. A. REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr, pp.67-355, 2011. ,
Presenting your structures: the CCP4mg molecular-graphics software, Acta Crystallogr. D, vol.67, pp.386-394, 2011. ,